CompanyTrack
C

CALON CARDIO-TECHNOLOGY LTD

Dissolved Swansea

Other research and experimental development on natural sciences and engineering

19 employees Website
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
C

CALON CARDIO-TECHNOLOGY LTD

Other research and experimental development on natural sciences and engineering

Founded 19 Mar 2007 Dissolved Swansea, United Kingdom 19 employees caloncardio.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 7 May 2024
Confirmation Statement Submitted 19 Mar 2025
Net assets £-2.22M £1.16M 2023 year on year
Total assets £641.88K £87.57K 2023 year on year
Total Liabilities £2.86M £1.25M 2023 year on year
Charges 2
1 outstanding 1 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

63 Walter Road Swansea SA1 4PT

Office ()

Swansea, Swansea, United Kingdom, Europe

Office (Wales, United Kingdom)

1b Sandringham Park, Swansea, SA6 8PW

Credit Report

Discover CALON CARDIO-TECHNOLOGY LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£93.53k

Decreased by £259.95k (-74%)

Net Assets

-£2.22M

Decreased by £1.16M (-110%)

Total Liabilities

£2.86M

Increased by £1.25M (+78%)

Turnover

N/A

Employees

19

Decreased by 2 (-10%)

Debt Ratio

445%

Increased by 155 (+53%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£10.5m raised
Show:

Investors (9)

Investor NameInvestor SinceParticipating Rounds
Development Bank of WalesMar 2010Series B, Series A
New Atlantis VenturesMar 2010Series A
Swansea InnovationsMar 2010Series A

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 3,835,247 Shares £8.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 May 202420,000£200£0.01
18 Feb 2023335,220£3k£0.01
9 Feb 20221,644£14k£8.6
9 Feb 20222,085$25k$12
9 Feb 2022100£860£8.6

Officers

Officers

5 active 11 resigned
Status
Andrew GoodwinDirectorBritishSwitzerland5326 Apr 2018Active
Lizbeth Ann ThomasDirectorAmericanUnited States706 May 2021Active
Robert Marc ClementDirectorBritishUnited Kingdom7226 Aug 2009Active
Ronald John PetersenDirectorAmericanEngland792 Nov 2011Active
Stephen WestabyDirectorBritishUnited Kingdom7726 Aug 2009Active

Shareholders

Shareholders (101)

Zequn Ma
0.3%
13,71019 Mar 2025
Wolfgang Beckman
0.0%
85219 Mar 2025
Wolfgang Beckman
0.0%
5519 Mar 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Mnl Nominees Ltd

United Kingdom

Active
Notified 5 Sept 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

MNL NOMINEES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
APEX UNITAS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
APEX VENTURES FUND SERVICES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
CALON CARDIO-TECHNOLOGY LTD Current Company

Charges

Charges

1 outstanding 1 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
20 Nov 2025InsolvencyLiquidation In Administration Statement Of Affairs With Form AttachedView(18 pages)
8 Sept 2025AddressChange Registered Office Address Company With Date Old Address New AddressView(3 pages)
8 Sept 2025InsolvencyLiquidation In Administration Appointment Of AdministratorView(3 pages)
19 Mar 2025Confirmation StatementConfirmation statement made on 2025-03-19 with updatesView(14 pages)
7 Mar 2025CapitalAllotment of shares (GBP 46,166.41) on 2024-05-28View(4 pages)
20 Nov 2025 Insolvency

Liquidation In Administration Statement Of Affairs With Form Attached

8 Sept 2025 Address

Change Registered Office Address Company With Date Old Address New Address

8 Sept 2025 Insolvency

Liquidation In Administration Appointment Of Administrator

19 Mar 2025 Confirmation Statement

Confirmation statement made on 2025-03-19 with updates

7 Mar 2025 Capital

Allotment of shares (GBP 46,166.41) on 2024-05-28

Recent Activity

Latest Activity

Liquidation In Administration Statement Of Affairs With Form Attached

2 months ago on 20 Nov 2025

Change Registered Office Address Company With Date Old Address New Address

5 months ago on 8 Sept 2025

Liquidation In Administration Appointment Of Administrator

5 months ago on 8 Sept 2025

Confirmation statement made on 2025-03-19 with updates

11 months ago on 19 Mar 2025

Allotment of shares (GBP 46,166.41) on 2024-05-28

11 months ago on 7 Mar 2025